Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Collaborates with Rabin Medical on Women's Health Biomarker Tests

NEW YORK (GenomeWeb News) – Rosetta Genomics will work with the Rabin Medical Center in Israel to develop microRNA-based tests for women’s health, the company said today.
 
The company plans to use microRNA biomarkers to develop “a wide range of diagnostic and prognostic tests” in oncology, gynecology, and obstetrics, the Rehovot, Israel-based company said.
 
"There is true unmet medical need for better diagnostics in women's health, and I am confident that the Rabin Medical Center's world-renowned researchers will assist us in bringing better diagnostics to patients worldwide,” Rosetta Genomics CEO Amir Avniel said in a statement.
 
The Rabin Medical Center, comprised of the Beilinson and Hasharon Hospitals, is headquartered near Tel Aviv, and many of its medical and research staff hold posts at the Tel Aviv University Sackler School of Medicine.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.